News from can-fite biopharma A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Jul 29, 2015, 07:00 ET

World Health Organization Accepted "Piclidenoson" as Proposed New Generic Name for Can-Fite's Lead Drug Candidate CF101

 Can-Fite BioPharma Ltd. (NYSE MKT: CANF) (TASE: CFBI), a biotechnology company with a pipeline of proprietary small molecule drugs that...

Jul 23, 2015, 07:00 ET

Can-Fite Joins Israeli Life Sciences Delegation to Japan on July 28 - 30, 2015

 Can-Fite BioPharma Ltd. (NYSE MKT: CANF) (TASE:CFBI), a biotechnology company with a pipeline of proprietary small molecule drugs that address...

Jun 29, 2015, 07:00 ET

Can-Fite's CF602 Sexual Dysfunction Drug Backed by New Preclinical Data Progresses Towards an IND

 Can-Fite BioPharma Ltd. (NYSE MKT: CANF) (TASE:CFBI), a biotechnology company with a pipeline of proprietary small molecule drugs that address...

Jun 19, 2015, 07:00 ET

Can-Fite Subsidiary OphthaliX Signs Definitive Agreement to Acquire Improved Vision Systems Ltd.

 Can-Fite BioPharma Ltd. (NYSE MKT: CANF) (TASE: CFBI), a biotechnology company with a pipeline of proprietary small molecule drugs being...

Jun 15, 2015, 07:00 ET

Can-Fite to Exhibit at Bio International Convention in Philadelphia on June 15 - 18, 2015

 Can-Fite BioPharma Ltd. (NYSE MKT: CANF) (TASE:CFBI), a biotechnology company with a pipeline of proprietary small molecule drugs being...

Jun 10, 2015, 07:00 ET

Can-Fite Granted Notice of Allowance for Patent Covering Manufacturing Process of CF101 in the U.S.

 Can-Fite BioPharma Ltd. (NYSE MKT: CANF) (TASE:CFBI), a biotechnology company with a pipeline of proprietary small molecule drugs being...

May 29, 2015, 07:00 ET

Can-Fite Reports First Quarter 2015 Results

 Can-Fite BioPharma Ltd. (NYSE MKT: CANF) (TASE:CFBI), a biotechnology company with a pipeline of proprietary small molecule drugs being...

May 11, 2015, 07:00 ET

Can-Fite's Phase II Liver Cancer Trial Approved in Europe

 Can-Fite BioPharma Ltd. (NYSE MKT: CANF) (TASE:CFBI), a biotechnology company with a pipeline of proprietary small molecule drugs being...

May 04, 2015, 08:50 ET

Can-Fite subsidiary, OphthaliX, Signs Term Sheet to Acquire Improved Vision Systems Ltd.

Can-Fite BioPharma Ltd. (NYSE MKT: CANF) (TASE:CFBI), a biotechnology company with a pipeline of proprietary small molecule drugs that address...

Apr 27, 2015, 07:00 ET

Can-Fite Reports Positive Results from Further Analysis of Phase II/III Psoriasis Trial

 Can-Fite BioPharma Ltd. (NYSE MKT: CANF) (TASE: CFBI), a biotechnology company with a pipeline of proprietary small molecule drugs that...

Apr 20, 2015, 07:00 ET

Can-Fite Applies for Orphan Drug Designation in Europe for CF102 in the Treatment of Liver Cancer

 Can-Fite BioPharma Ltd. (NYSE MKT: CANF) (TASE: CFBI), a biotechnology company with a pipeline of proprietary small molecule drugs that are...

Mar 30, 2015, 09:11 ET

Can-Fite Reports Top-Line Results from Phase II/III Trial for CF101 in Treatment of Psoriasis

Can-Fite BioPharma Ltd. (NYSE MKT: CANF) (TASE:CFBI), a biotechnology company with a pipeline of proprietary small molecule drugs that address...

Mar 27, 2015, 16:29 ET

Can-Fite Files 2014 Annual Report on Form 20-F

 Can-Fite BioPharma Ltd. (NYSE MKT: CANF) (TASE:CFBI), a biotechnology company with a pipeline of proprietary small molecule drugs that are...

Mar 23, 2015, 07:00 ET

Can-Fite Signs Multi-Million Dollar Distribution Agreement for CF101 in Canada with Cipher Pharmaceuticals

 Can-Fite BioPharma Ltd. (NYSE MKT: CANF) (TASE:CFBI), a biotechnology company with a pipeline of proprietary small molecule drugs that are...

Mar 18, 2015, 07:00 ET

Can-Fite Completes Development of Commercial Biomarker Test to Predict Patients' Response to Company Drugs

Can-Fite BioPharma Ltd. (NYSE MKT: CANF) (TASE:CFBI), a biotechnology company with a pipeline of proprietary small molecule drugs that are being...

Feb 17, 2015, 07:00 ET

Can-Fite Receives Notice of Allowance in U.S. for Psoriasis Patent

Can-Fite BioPharma Ltd. (NYSE MKT: CANF) (TASE:CFBI), a biotechnology company with a pipeline of proprietary small molecule drugs that are being...

Feb 04, 2015, 07:00 ET

Can-Fite Completes Phase II/III Trial for CF101 in Treatment of Psoriasis

Can-Fite BioPharma Ltd. (NYSE MKT: CANF) (TASE:CFBI), a biotechnology company with a pipeline of proprietary small molecule drugs that address...

Jan 27, 2015, 07:00 ET

Can-Fite's CF602 Demonstrates Efficacy in Treatment of Sexual Dysfunction in Preclinical Studies

 Can-Fite BioPharma Ltd. (NYSE MKT: CANF) (TASE:CFBI), a biotechnology company with a pipeline of proprietary small molecule drugs that address...

Jan 06, 2015, 07:15 ET

Can-Fite Announces Upcoming 2015 Clinical Milestones for its Pipeline of Drugs in 4 Indications

 Can-Fite BioPharma Ltd. (NYSE MKT: CANF) (TASE: CFBI), a biotechnology company advancing a pipeline of proprietary small molecule drugs that...

Dec 30, 2014, 07:00 ET

Can-Fite Completes the Design of the Rheumatoid Arthritis Phase III Study of Its Lead Drug Candidate CF101

 Can-Fite BioPharma Ltd. (NYSE MKT:CANF) (TASE:CFBI), a biotechnology company with a pipeline of proprietary small molecule drugs that address...